In contrast, Balan and colleagues agreed with the initial finding of an association between the GABRG2 C588T C allele and the CC genotype with mesial temporal lobe epilepsy and juvenile myoclonic epilepsy but could not find a real effect of different genotypes on the efficacy of ASMs [5]. The gene discussed is GABRG2; the disease is juvenile myoclonic epilepsy.